IGFBP3 and melanoma: Interestingly, studies in melanoma demonstrate that in early phases of tumor growth and metastasis where IGFBP-3 expression is reduced due to promoter hypermethylation [64], elevated IGFBP-3 inhibits Wnt/β-catenin signaling, reducing metastatic potential [65].